ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $114,264,692 | +1.9% | 4,210,195 | +15.4% | 0.02% | 0.0% |
Q2 2023 | $112,110,502 | +35.1% | 3,647,056 | +58.3% | 0.02% | +27.8% |
Q1 2023 | $82,989,520 | +71.9% | 2,303,345 | +88.6% | 0.02% | +63.6% |
Q4 2022 | $48,272,059 | -12.7% | 1,221,459 | -11.3% | 0.01% | -15.4% |
Q3 2022 | $55,316,000 | +33.4% | 1,376,705 | +39.6% | 0.01% | +44.4% |
Q2 2022 | $41,473,000 | -28.4% | 986,527 | -33.7% | 0.01% | -25.0% |
Q1 2022 | $57,958,000 | +11.4% | 1,487,630 | +13.9% | 0.01% | +20.0% |
Q4 2021 | $52,025,000 | +60.4% | 1,305,520 | +45.5% | 0.01% | +42.9% |
Q3 2021 | $32,432,000 | -23.3% | 897,403 | -13.1% | 0.01% | -30.0% |
Q2 2021 | $42,306,000 | +147.3% | 1,032,101 | +163.2% | 0.01% | +150.0% |
Q1 2021 | $17,107,000 | -35.2% | 392,170 | -25.7% | 0.00% | -42.9% |
Q4 2020 | $26,414,000 | +256.9% | 527,760 | +200.0% | 0.01% | +250.0% |
Q3 2020 | $7,400,000 | +401.4% | 175,903 | +478.6% | 0.00% | – |
Q2 2020 | $1,476,000 | – | 30,403 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |